Fortsæt til indhold

Main Navigation

Chr. Olesen Synthesis Chr. Olesen Synthesis
  • Products
  • Expertise
  • About
  • Contact

Major event

Udgivet den april 29, 2021 (april 29, 2021) af Ditlev

Novartis acquired Hexal and merged it with Sandoz to create a leading generics player

Indlæg navigation

 Ownership change 2007 – 2011Ownership change 2005 – 2007 

Seneste kommentarer

    Contact

    Chr. Olesen Synthesis A/S
    Kanalholmen 8-12
    DK-2650 Hvidovre
    Denmark

    Tel.: +45 3679 4500
    E-mail: info@cosynthesis.dk

    Links

    • Products
    • Expertise
    • About
    • Contact

    About

    Chr. Olesen Synthesis is focusing on controlled substances and molecules like Buprenorphine, Dexamphetamine & Hydromorphone. In addition we can offer a selection of other APIs and advanced intermediates.

    Legal

    Privacy Policy / Cookies Whistleblowerordningen
    ©2023 Chr. Olesen Synthesis